Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride users have higher odds of certain health issues and lower odds of specific lifestyle factors compared to nonusers.

Presurgical models can effectively and affordably screen cancer prevention agents.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Using finasteride 0.5% solution with laser therapy significantly reduces unwanted facial hair in women.

Finasteride may affect PNMT, causing side effects.

Finasteride slightly improves prostate symptoms but has minimal difference from placebo.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Promising cancer treatments were found, but the manufacturer closed.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Reporter characteristics affect detection of hair loss from cancer therapy.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

New method accurately measures finasteride in tablets.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Sonidegib often causes hair loss, and LC-OCT helps identify early signs.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Finasteride treatment increased blood volume and reduced vessel leakiness in beagle prostates.

Metabolic syndrome reduces effectiveness of hair loss treatment.